During this 60-minute webinar, expert speakers Kimberly Hoy, JD, CPC, and Valerie Rinkle, MPH, CHRI, will explain how to navigate compliance with off-campus provider-based department (PBD) regulations, including recent changes to regulatory guidance and requirements, how to navigate deadlines...
A bipartisan group of senators introduced a bill in early August to clarify requirements, increase oversight, and reform the payment and data infrastructure of the 340B Drug Pricing Program.
As documentation requirements grow more complex and payer scrutiny continues to increase, many healthcare organizations are discovering that maintaining documentation integrity requires more than...
In a recent letter, HHS called on the Office of Inspector General (OIG) to examine healthcare organizations’ billing of gender-affirming care provided to minors.
Listening to a NAHRI Quarterly Member Call (free for NAHRI members) qualifies for one CHRI CEU credit upon the completion of the accompanying survey. If you’re a NAHRI member and are interested in presenting on an upcoming NAHRI members-only call, please contact NAHRI at...
Denials rarely start at the payer. They often begin upstream, in the gaps between clinical, financial and quality workflows, where teams may be aligned in purpose but disconnected by process. In this fireside chat healthcare leaders...
Hospitals could be facing lower reimbursement for non-drug items and services, 340B drugs, excepted off-campus provider-based department (PBD) services, as well as additional price transparency and prior authorization requirements, according to CMS’ 2027 Outpatient Prospective Payment System (OPPS) proposed rule.
